Palivizumab (Synagis; MedImmune/Abbott) is a humanized murine monoclonal antibody against the RSV fusion protein that prevents the spread of virus to the lower respiratory tract 2. It was approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback